Citywire for Financial Professionals
Stay connected:

View the article online at

JP Morgan Claverhouse: cheap, but not good value

With a discount of around 9% the JP Morgan Claverhouse investment trust might look like a bargain, but performance has been lacklustre, says James Carthew.

JP Morgan Claverhouse: cheap, but not good value

James Carthew, a director of Sapient Research, gives his view on the JP Morgan Claverhouse investment trust

JP Morgan Claverhouse opted to be designated as part of the 'UK Growth and Income sector', as defined by the AIC trade association, in May this year.

The shift from the UK Growth sector made sense as Claverhouse had, for some time, paid a much higher yield than most of its competitors, and I think the board believed if it was recognised as an income fund the rating might improve. Right now though, the discount is still one of the widest in its sector.

Claverhouse is a £222 million market cap fund, a lot smaller than it was a decade ago thanks to buy-backs, but still a reasonable size. Like most of the group it uses the FTSE All-Share Index as its benchmark. The fund has a slight bias to small and medium-sized companies relative to this index (with small-cap exposure provided through investments in JP Morgan small cap funds) but the portfolio will always be dominated by large companies.

Fee structure

Fees are reasonable at 0.55% of market cap. There is a performance fee of 15% of returns generated over 0.5% above the benchmark and this is capped at 0.4% of net assets and paid over three years. The objective is to deliver returns of 2% per annum above the benchmark over rolling three-year periods, so the board has designed the performance fee to be a ‘normal’ part of JP Morgan’s remuneration.

The yield is 4.4%, which is towards the top quartile of growth and income funds; dividends are paid quarterly. The dividend has not been covered by earnings for the past couple of years, however. There are revenue reserves (and they could now opt to distribute capital) but the aim is to fully cover the dividend. This may restrict dividend growth for a while.

There is some long-term debt in the form of a £30 million 7% debenture that matures in 2020. Repaying the debenture early would be expensive. The board has decided that this money should normally be fully invested – ie, there would always be a modest level of gearing. For the moment, much of the debt is offset by cash deposits – while this situation persists there will be a modest drag on capital performance and income.

Unimpressive performance

Claverhouse’s performance relative to its benchmark does not look all that marvellous and has not done so for some time. The fund was managed with the same investment process that drives stock selection on most of JP Morgan’s funds.

This has struggled to generate outperformance in some markets in recent years: stablemate JP Morgan Mid Cap has also disappointed, for example. After Claverhouse underperformed its benchmark in four out of five years, the board decided action was needed. In March this year, after working with an independent consultant, JP Morgan proposed adopting a more concentrated portfolio.

Previously the fund had more than 100 holdings, the idea was that this would be reduced to between 60 and 80 – not particularly focused by the standards of some funds, but the board hoped JP Morgan’s stock selection decisions would have a greater impact and they would be more overweight the companies where they had the greatest conviction.

Management shake-up

James Illsley, manager of the fund since 2002, was replaced by William Meadon. Sarah Emly stayed on as co-manager. The notice period was reduced to three months (in the event that underperformance continues, one year otherwise).

By the end of June they had reduced the number of holdings to 64, which is a step in the right direction. They have underperformed the benchmark in the few months since they changed the investment approach, but I think not enough time has elapsed for that to be any indication of things to come.

Sign in / register to view full article on one page

1 comment so far. Why not have your say?


Aug 24, 2012 at 17:21

While JP Morgan appear to have refrained from radical experiments with ITs under their wing since taking over Flemings no-nonsense ITs a decade ago, performance has been less than spectacular with a few notable exceptions such as Mercantile, European Smaller Companies and JPM Emerging. The reasons for such an outcome are difficult to pinpoint, but whereas JPM have sought to generate volume retail sales (following the plodding Alliance Trust) others such as Schroders, Law Debenture, Baillie Gifford and even the venerable Scottish Investment Trust have spruced up their portfolios with more exotic fare. Nonetheless, even buy-and-hold ITs such as Lowland and Independent have enjoyed occasional spurts, so identifying any specific magic formula appears to be a hit and miss affair.

report this

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

The Citywire Guide to Investment Trusts

In this guide to investment trusts, produced in association with Aberdeen Asset Management, we spoke to many of the leading experts in the field to find out more.

Watch Now

More about this:

Look up the investment trusts

  • JPMorgan Claverhouse (Ordinary Share)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • JPMorgan Smaller Companies (Ordinary Share)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them
  • JPMorgan Mid Cap (Ordinary Share)
    Register or Sign in to receive email alerts for items in your favourites whenever we write about them


Today's articles

Tools from Citywire Money

From the Forums

+ Start a new discussion

Weekly email from The Lolly

Get simple, easy ways to make more from your money. Just enter your email address below

An error occured while subscribing your email. Please try again later.

Thank you for registering for your weekly newsletter from The Lolly.

Keep an eye out for us in your inbox, and please add to your safe senders list so we don't get junked.

Sorry, this link is not
quite ready yet